1. Home
  2. Stock quotes
  3. Enlivex Therapeutics Ltd.
  4. Financial Statements
  5. Cash Flow
Enlivex Therapeutics Ltd. logo
Enlivex Therapeutics Ltd. ENLV
$ 1.25 5.81%
mail-toReport an Error

Annual report 2023
added 12-21-2024

report update icon

Enlivex Therapeutics Ltd. Cash Flow 2011-2024 | ENLV

Annual Cash Flow Enlivex Therapeutics Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

 -23.5 M -24 M -17.5 M -11 M -7.04 M -3.16 M -2.3 M -15.5 M -13.2 M - - - -

Depreciation & Amortization

 - - 546 K 286 K 206 K 121 K 83 K 38 K 17 K 5 K - - -

Accounts Payables

 - - - 463 K 316 K 16 K 37 K 700 K 1.41 M 1.28 M - - -

Accounts Receivables

 - - - - - - 28 K 52 K 145 K 93 K - - -

Total Inventories

 - - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Enlivex Therapeutics Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

 - - - - - - 122 K - - - 60 K - - - 92 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

 - - - - 878 K - 558 K - 463 K - 524 K - 316 K - - - 173 K - - - 19 K - - - 700 K - - - 1.41 M - - - 1.28 M - - - 46 K - - - - - - - - - - -

Accounts Receivables

 - - - - - - - - - - - - - - - - 16 K - - - 28 K - - - 52 K - - - 145 K - - - 93 K - - - 26 K - - - - - - - - - - -

Total Inventories

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency